Credit Suisse’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-22,966
| Closed | -$343K | – | 3950 |
|
2022
Q4 | $343K | Buy |
+22,966
| New | +$343K | ﹤0.01% | 2953 |
|
2019
Q3 | – | Sell |
-2,244
| Closed | -$16K | – | 3544 |
|
2019
Q2 | $16K | Sell |
2,244
-332
| -13% | -$2.37K | ﹤0.01% | 3405 |
|
2019
Q1 | $21K | Buy |
2,576
+714
| +38% | +$5.82K | ﹤0.01% | 3346 |
|
2018
Q4 | $30K | Buy |
+1,862
| New | +$30K | ﹤0.01% | 3287 |
|
2018
Q3 | – | Sell |
-2,840
| Closed | -$65K | – | 3510 |
|
2018
Q2 | $65K | Buy |
2,840
+1,193
| +72% | +$27.3K | ﹤0.01% | 3415 |
|
2018
Q1 | $48K | Sell |
1,647
-885
| -35% | -$25.8K | ﹤0.01% | 3455 |
|
2017
Q4 | $70K | Buy |
+2,532
| New | +$70K | ﹤0.01% | 3383 |
|
2015
Q1 | – | Sell |
-3,468
| Closed | -$29K | – | 4240 |
|
2014
Q4 | $29K | Buy |
+3,468
| New | +$29K | ﹤0.01% | 4152 |
|
2014
Q3 | – | Sell |
-6,607
| Closed | -$121K | – | 4241 |
|
2014
Q2 | $121K | Buy |
6,607
+3,739
| +130% | +$68.5K | ﹤0.01% | 4074 |
|
2014
Q1 | $43K | Sell |
2,868
-5,154
| -64% | -$77.3K | ﹤0.01% | 4204 |
|
2013
Q4 | $147K | Buy |
8,022
+3,734
| +87% | +$68.4K | ﹤0.01% | 3951 |
|
2013
Q3 | $88K | Sell |
4,288
-79,815
| -95% | -$1.64M | ﹤0.01% | 3690 |
|
2013
Q2 | $2.1M | Buy |
+84,103
| New | +$2.1M | ﹤0.01% | 1904 |
|